Researching: Novo Nordisk
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Novo Nordisk"...
RxInsider Coverage (10)
The Week
The Oral GLP-1 Tracker: Holiday takes toll on prescriptions
Sep 21
The Week
STAT+: What's in a name? Novo looks to a rebrand
Sep 14
The Week
STAT+: Novartis, Novo Nordisk drug failures will likely 'pop a hole in the balloon' of the field
Sep 11
The Week
Novo's blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Sep 8
The Week
Medicare’s $50 GLP-1 bridge model gives Lilly and Novo a demand signal
Sep 4
The Week
Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients
Aug 31
The Week
Lilly's Mounjaro wins US label expansion for cardiovascular risk reduction
Aug 28
The Week
Pharma's new CEOs to watch
Aug 27
The Week
How cost and perception could reshape the GLP-1 market
Aug 21
The Week
How cost and perception could reshape the GLP-1 market
Aug 19
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.